Verona Pharma (VRP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

142.00p
   
  • Change Today:
    -1.50p
  • 52 Week High: 206.25
  • 52 Week Low: 125.00
  • Currency: UK Pounds
  • Shares Issued: 51.36m
  • Volume: 12,409
  • Market Cap: 72.93m
  • RiskGrade: 201
  • Beta: 1.07

Verona Pharma Overview

Verona Pharma is developing first in class drugs to treat respiratory disease such as COPD asthma and chronic severe cough

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 2.1  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Verona Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 n/a (2.57) (39.35)p n/a n/a n/a n/a 0.0%
31-Dec-13 n/a (2.81) (35.51)p n/a n/a n/a n/a 0.0%
31-Dec-14 n/a (3.76) (16.00)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (9.00) (1,855.00)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (5.97) (749.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Verona Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 n/a (14.05) (26.29)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a 55.26 109.15p 1.3 n/a n/a n/a 0.0%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

Verona Pharma Company Announcements

Services Agreement with QuintilesIMS 22-Mar-2017 07:00 RNS
Posting of Annual report & Notice of AGM 20-Mar-2017 13:55 RNS
PDMR Dealing 02-Mar-2017 09:36 RNS

Latest Verona Pharma Director Deals

Traded Action Notifier PriceAmountValue
01-Mar-17 Buy Sven Jan-Anders Karlsson 149.00p 7,750 11,547.50
28-Feb-17 Buy Sven Jan-Anders Karlsson 149.00p 12,000 17,880.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Verona Pharma Market Data

Currency UK Pounds
Share Price 142.00p
Change Today -1.50p
% Change -1.05 %
52 Week High 206.25
52 Week Low 125.00
Volume 12,409
Shares Issued 51.36m
Market Cap 72.93m
Beta 1.07
RiskGrade 201

Verona Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
18.71% below the market average18.71% below the market average18.71% below the market average18.71% below the market average18.71% below the market average
Sector averageSector averageSector averageSector averageSector average
Price Trend
65.72% below the market average65.72% below the market average65.72% below the market average65.72% below the market average65.72% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average
Income Not Available
Growth Not Available

Verona Pharma Dividends

No dividends found

Trades for 24-Mar-2017

Time Volume / Share Price
16:10 245 @ 138.80p
16:00 1,034 @ 145.00p
13:23 1,898 @ 139.00p
13:17 1,700 @ 139.00p
13:12 1,402 @ 139.00p

Verona Pharma Key Personnel

CEO Sven Jan-Anders Karlsson
CFO Biresh Roy
CFO Piers Morgan

Top of Page